Espicom's in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. With a population now in excess of 80 million, the Philippines is the third-largest country in the Association of South East Asian Nations (ASEAN), behind Indonesia and Vietnam. The Philippines is composed of a vast number of islands, although much of the country's wealth is based in the Metro Manila region on the island of Luzon, where much of the pharmaceutical market is based. It is here where disposable incomes are highest, and where the majority of the country's high class medical facilities and staff are located.

The Philippines is a relatively poor country where only a small majority of the country has access to adequate healthcare provision and even fewer can afford the high drug prices. The government has been actively promoting the use of generics in recent years, as branded pharmaceuticals are expensive in a country with very low GDP per capita. Domestic manufacturing is limited and imports make up a large proportion of the market.

Administration of the health sector is highly devolved to local government units. This can make planning and co-ordination difficult. Between 50% and 60% of healthcare expenditure and provision is in the private sector. An exodus of medical staff overseas in pursuit of better wages and working conditions has put severe pressure on healthcare services. The Philippines currently has around 1.2 doctors per thousand population.

The Philippine pharmaceutical market is valued at US$1.3 billion in 2007. This is equal to around US$15 per capita, comparable with neighbouring countries such as China and Iran.